Clinical Trials Logo

Clinical Trial Summary

Researchers are trying to determine if the vitamin B3 derivative Nicotinamide Riboside (NR) has any effects in bone, skeletal muscle, and metabolic functions and structure in aging.


Clinical Trial Description

Primary Objective: To assess the effect of "NAD boosting" through NR intake in skeletal muscle and bone metabolism function, and biochemical evidence of improvement of DNA damage repair in healthy elderly female patients with and without exercise. Secondary Objective: To assess the effect of NR in metabolic functions of glucose and lipid profile as well as to determine the safety of long term administration of NR in healthy elderly female patients with and without exercise. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03818802
Study type Interventional
Source Mayo Clinic
Contact Jeremy Smith, MD
Phone 507-266-1944
Email smith.jeremy@mayo.edu
Status Recruiting
Phase N/A
Start date September 16, 2019
Completion date December 2024

See also
  Status Clinical Trial Phase
Terminated NCT01215552 - Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712 Phase 1
Completed NCT00903253 - A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers Phase 1
Completed NCT01795339 - A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients Phase 1
Completed NCT01739647 - A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects Phase 1